The deubiquitinating enzyme USP1:UAF1, a therapeutic target in cancer (Rennie et al, 2024), normally removes ubiquitin from FANCD2 unless FANCI is also modified (Lemonidis et al, 2023; Rennie et al, 2020; van Twest et al, 2017). Here, FANCI is linked to cancer.